Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $5.45 Analyst target: $12.28 Upside: 125.32%
Valneva SE, a company specialized in vaccines, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. The company is headquartered in Saint-Herblain, France.
See the full interactive analysis & chart →Informational only — not investment advice.